Interaction of 1-methyl-4-phenylpyridinium ion with human platelets

This publication has 11 references indexed in Scilit:

• Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine
  Journal of Neurochemistry, 1987
• Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium
  Journal of Neurochemistry, 1986
• Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+
  Biochemical and Biophysical Research Communications, 1986
• Photoinactivation of B-type monoamine oxidase by a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolite.
  Journal of Biological Chemistry, 1985
• Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B
  Neuroscience Letters, 1985
• Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes
  Biochemical and Biophysical Research Communications, 1985
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
  Proceedings of the National Academy of Sciences, 1985
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• [4] Firefly luciferase assay for ATP production by mitochondria
  Published by Elsevier ,1978
• Influence of medium tonicity on respiration by suspensions of human platelets
  American Journal of Physiology-Legacy Content, 1976